Illumina (NASDAQ:ILMN – Free Report) had its price target lifted by Robert W. Baird from $125.00 to $128.00 in a research report report published on Friday morning, Benzinga reports. The brokerage currently has a neutral rating on the life sciences company’s stock. Several other equities research analysts have also issued reports on ILMN. TD Cowen […]
Illumina (NASDAQ:ILMN – Free Report) had its target price lifted by Robert W. Baird from $125.00 to $128.00 in a research report released on Friday morning, Benzinga reports. They currently have a neutral rating on the life sciences company’s stock. A number of other equities analysts also recently issued reports on the stock. Stephens reissued […]
Legacy Financial Advisors Inc. bought a new stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 1,835 shares of the life sciences company’s stock, valued at approximately $256,000. Several other hedge funds have also made changes to their positions in ILMN. Annis Gardner Whiting Capital Advisors […]
JFG Wealth Management LLC purchased a new stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 2,000 shares of the life sciences company’s stock, valued at approximately $278,000. Several other large investors also recently made changes to […]
Motley Fool Asset Management LLC raised its position in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 6.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,314 shares of the life sciences company’s stock after purchasing an additional 266 shares […]